APP and Alzheimer disease: This observation may inform design of future passive immunization experiments in APP Tg model mice of AD and clinical trials suggesting specific tailoring of the anti-Aβ passive immunization protocol in APOE ε4 allele carriers to achieve end-point plaque load reduction level compared to that expected among non-ε4 allele carriers.